key: cord-0819776-a6gt8h6k authors: Kamel, Omar; Rozen, Laurence; Lecomte, Sophie; Heimann, Pierre; Demulder, Anne title: Pleural effusion as a rare sign of anaplastic large‐cell lymphoma in a COVID‐19 patient: A case report and literature review date: 2021-03-24 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13521 sha: a660cd48b972f0f94ba5465af2b81135a2c37918 doc_id: 819776 cord_uid: a6gt8h6k nan Dear Editors, COVID-19 can induce pleiotropic symptoms and laboratory abnormalities. With this case report, we would like to raise awareness that COVID-19 is not a "catchall" diagnosis. A 58-year-old man presented to the emergency department for dyspnea worsening since the last 5 days. In his history, he suffers from chronic obstructive pulmonary disease (COPD) GOLD II due to active smoking, arterial hypertension, atrial fibrillation, and obesity. He presented with bilateral pneumonia in October 2019 of unknown etiology treated successfully empirically with amoxicillin/clavulanic acid and clarithromycin. At that time, a chronic lymphopenia (around 400 lymphocytes/µL) is already present, but not explored. On admission, the patient was apyretic and had a blood pressure of 106/76 mmHg, 106/min heart rate, and oxygen saturation at 86%. Laboratory main findings showed a worsening of his lymphopenia (40 lymphocytes/µL, reference value: 1.2-3.5 10 3 /µL), high D-dimer level (3570 ng/mL, reference value 0-500 ng/mL) normal platelet and white blood cell count, negative serology for HIV, treponema, hepatitis B and C, and a positive SARS-CoV-2 RT-PCR. Chest scan showed no pulmonary embolism, a pleural effusion, and 35% of lungs surface lesions highly suggestive of COVID-19 infection. Patient was hospitalized, and azithromycin, hydroxychloroquine, cefuroxime, and oxygen therapy were administered. A pleural tap was performed, showing 2900 red blood cells/µL and 1710 leukocytes/µL with 93% lymphocytes and 7% neutrophils. Lymphocytes displayed a highly basophilic cytoplasm, and clearly visible nucleolus By this case report, we want to draw attention that symptoms of presentation of hemato-oncological diseases, for example, lymphopenia and abnormal cell morphology, may be similar to those of COVID-19 and that differential diagnosis must be kept in mind. Lymphomas and hematological neoplasms are important to be ruled out in a context of COVID-19 suspicion. Patients suffering from COVID-19 infection with an underlying cancer are at higher risk of more severe outcomes, with hematological cancers having the highest severity and death rates among all cancers. 11 Lymphomas may present with cough, with or without fever, and possibly with a pleural effusion, which is also being described and added to the clinical spectrum of COVID-19. 12 In the particular context of the COVID-19 pandemic, our patient's symptoms have been integrated into a clinical picture of viral F I G U R E 2 Immunohistochemical staining for CD30 and ALK. Pathological cells (black arrows) show negative ALK staining (A: ×400) and strong CD30 staining (B: ×400 and C: ×1000). Hallmark and "doughnut" cells (D: H&E staining × 1000) can be found and are targeted with black arrows. Neutrophils are marked with red arrows and can be used as a scale to assess hallmark cells width infection. In retrospect, the initial chronic lymphopenia and possibly primary lesions should have been the subject of an initial assessment as the underlying diagnosis was probably present prior to the COVID-19 infection phase. The final diagnosis was already of poor prognosis, further complicated by a severe SARS-CoV-2 infection which explains the rapidly declining clinical evolution of our patient. The authors have no competing interests. LR, AD, and OK collected the data for the manuscript. SL and PH performed the immunohistochemical staining and genetic analysis, respectively. OK wrote the manuscript. All authors reviewed and approved submission of the manuscript. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Hematological findings and complications of COVID -19 Clinical features of patients infected with 2019 novel coronavirus in Wuhan The Pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers The biology and management of systemic anaplastic large cell lymphoma Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma Diffuse pulmonary infiltration by anaplastic lymphoma kinase negative anaplastic large cell lymphoma: a case report and literature review Anaplastic large cell lymphoma manifesting as pleural effusion in a patient with long-standing eosinophilia hallmark" cells Morphology of COVID-19-affected cells in peripheral blood film Atypical lymphocytes in peripheral blood of patients with COVID-19 Case fatality rate of cancer patients with COVID-19 in a New York hospital system Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease